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The presence of Sa-reductase (5a-R) in skin may 
indicate that the androgen regulation of sebaceous 
glands and sebum production requires the local con-
version of testosterone to dihydrotestosterone. The 
goals of this study were to identify which isozyme of 
5a-R (type 1 or type 2) is expressed in sebaceous 
glands from facial areas, scalp, and non-acne-prone 
areas; to determine if 5a-R activity is concentrated in 
sebaceous glands; to assess whether there are re-
gional differences in this enzyme's activity; and to 
test the effects of azasteroid inhibitors and 13-cis 
retinoic acid on 5a-R in these tissues. Sebaceous 
glands were microdissected from facial skin, scalp, 
and non-acne-prone skin (arm, breast, abdomen, 
leg), and the activity of 5a-R was determined. A total 
of 49 samples from 23 male and 21 female subjects 
without acne (age range, 16 to 81 years, 56 ± 20 years 
[mean ± SD]) was analyzed. The biochemical prop-
erties of the enzyme in each of the samples tested are 
consistent with those of the type 1 5a-R. Minimal to 
no type 2 5a-R was detected. The level of 5a-R 
activity was significantly higher in the sebaceous 
glands compared to whole skin in facial skin (p = 
A ndrogens are know n to p lay a ro le in acne throug h modulation of sebum pro duction [1-4). The re lative impo rtan ce of th e androgen(s) in volved and their source (gonadal, adrenal, or target ti ssu e) is not known. There is mounting eviden ce that target 
tissue production of androgens may b e most impo rtant ill sebum 
production [5-8). In this rega rd , dihydrotes tostero ne (DHT) is the 
target ti ssue-produced androgen presumed to be m ost active. DHT 
is produced fi·om testosterone by the action of the Sa-reductase 
(S a -R) enzyme. Several groups reported that high levels of Sa-R 
activity are associated with the sebaceous glands, whereas lower 
levels were observed in the epide rmi s and dermis [9-t3). Since the 
time of those studies it has become cl ear that the re are two gen es 
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0.047), scalp (p = 0.039), and non-acne-prone skin (p 
= 0.04). Enzyme activity in sebaceous glands from 
facial skin and scalp was significantly higher than in a 
comparable amount of sebaceous gland material ob-
tained from non-acne-prone areas (32 ± 6 [mean ± 
SEM]), 35 ± 7 (mean ± SEM) versus 6.0 ± 3.0 (mean ± 
SEM) pmollmin/mg protein, p = 0.014 and 0.007, 
respectively). Finasteride and 1.3-cis retinoic acid 
were poor inhibitors of the enzyme with 50% inhibi-
tory concentration values greater than 500 nM. These 
data demonstrate that in the skin from olde r patients 
without acne the type 1 isozyme of 5a-R predomi-
nates, its activity is concentrated in sebaceous glands 
and is significantly higher in sebaceous glands from 
the face and scalp compared to non-acne-prone ar-
eas, and the action of 13-cis retinoic acid in the 
control of acne is not at the level of 5a-R. Further-
more, we suggest that specific inhibition of the type 1 
5a-R may offer a viable approach to the management 
of sebum production and, hence, acne. Ke}' words: 
dilrJidrotestostevonelaudrogeusltes to.~teroue/acue. ] Irwest 
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encoding two distinct isozymes of Sa-R tha t ar c differentially 
eA-prcssed in hw11an tissu es [14-16). T h e type 2 isozyme is found in 
the prostate and cultured derm al papilla ft·o m the beard region (17]. 
is m ost active at pH 5, and is sensitiv e to inhibitio n by finasteride. 
T he type 1 isozym e is m ost active at pH 7 and h as been identifi ed 
in the sca lp (18) and skin fro n1 th e chest fl9) and pubic region [20]. 
In recent repo rts, the clinical benefits of 13- cis-J·etin oic acid 
(isotretinoin) we re attributed to inhibitio n of Sa-R [21 ,22); how-
ever , n o attempt was made in human sebaceous g lands to study the 
iu 11itro inhibition of this en zym e . T h e goa l of our study is to further 
characterize androgen m etab o lism in the skin by 1) iden tifYing the 
Sa-l~ isozym e o pen1tive in isolated sebaceous g land s a.n d w hole 
skin from the face, sca lp , and n o n-acne-pro n e areas; 2) com paring 
the level of activity ofSa-R in sebaceous g lands and whole skin , 3) 
assessing regiona l diffe rences in Sa-R activity in facial , scalp, and 
non-acne-prone skin, and 4) studyin g the inhibitio n of Sa-R by 
13-cis-reti n o ie acid and two azaste ro ids. A finding of regio nal 
diffe ren ces in Sa-R activity m ay explain th e '!na tomi c loca li za tion 
of acne to the sebaceous follicles of f.1ce , an terior chest, and back . 
Furthermore, if DHT is responsible for sebum productio n , use of a 
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specific inhibitor to the isozyme active in sebaceous g lands m ay be 
of therapeutic benefit in acne. 
MATEIUALS AND METHODS · 
Skin Specitnens Sam ples of norma l skin were obta ined from routine 
surgeries perfonned in the Divis ion of Dermatology and the Department of 
Surgery at T he Pennsylvania State University's Hershey Med ica l Center and 
the Department of Dermatology at the University of Minnesota Hospital. 
Samples of human sca lp skin from non-bald ing occipi tal regions were 
obmincd at the time of hair transp lant. All specimens were frozen in hquid 
N 2 and stored at - 80°C. Dissection of skin was performed acco rdin g to the 
method of Sawaya el a/ 123] . T he iso lated g lands were placed in Hanks' 
balanced sa lt solu tio n (HBSS) and were frozen at - 80°C for fu ture 
incubation studies. 
Incubation Assay of Sa-Reductase Activity 1-lomogenates of seba-
ceous glands from fac ial skin, scalp , and non-acne-prone regions were 
prepared in HBSS conta ining l mM phcnylmethylsulfonyl Auoride (PMSF), 
1 mM dithiothreitol (OTT) , 0.25 M sucrose, and 20% (v/v) glyce ro l in a 
P. .. adnoti precision microgrinder. Whole skin homogenates were prepared in 
the same manner eithe r using a Wheaton homogenizer or tissues were fi rst 
pulverized using a SPEX freezer mill (Linden, NJ). Protein content of the 
sebaceous gland and whole skin homogenates were determined using either 
the Pierce BCA protein assay o r the method of Lowry et nf [24]. A minimum 
of 40 to 80 p.g of protein (depending on the tissue source) was required to 
perform the incubation assay. The incubation cockta il consisted of[1 ,2-3 1-1 ) 
testosterone (10<' dpm) in the presence of 1-10 j.LM nonradioactive testos-
terone, 500 p.M NADPH, 1 mM OTT, 40-80 p.g of homogenate protein in 
a final vo lume of 0.1-0.2 ml of succinic acid/ imidazole/diethanolamine 
buffer with pH adjusted depending on the study being performed . For all 
assays performed, a negative control, consisting of all components of the 
incubation cocktail except for the homogenate was assayed. Each reaction 
mixture was incubated in a -5% C02 incubator at 37°C fo r 30 min . T he 
reactions were stopped by the add ition ofl ml of cyclohexanc/ethyl acetate 
(70:30, v/v) containing 100 p.g of each of th e fo llowing nonradioactive 
ca rrier steroids: androstenedione, testosterone, DHT, 5cr-androstane-
3cr, 17{3 dio l, and Scr-androstane-3{3, 17 {3 dio l. After termination of the 
reaction, samples were extracted again with chloroform/ ethyl acetate 
(70:30) and the pooled extracts evaporated to near dryness under nitrogen. 
The sample extracts were disso lved in ethyl acetate prior to chromato-
graphic separation. 
Separation of Androgens Androgens were separated either by high-
performance liquid chromatography using previously published methods 
[18] or thin-layer chromatography. Thin-layer plastic plates (20 em X 20 
em) coated with silica ge l G, conta ining a fluorescent indicator (Alltech) 
were used. Plates were first washed by development in methanol. After 
be ing developed twice at room temperature in a solvent system of chloro-
form/methanol (99:1, v/v) , the 3-keto-ll4 carrier steroids were visua lized 
by u ltraviolet light and the other steroids were visuali zed by exposure to 
iodine va por. Rr val ues of 0.32, 0.41, 0.57, and 0.74 were o btain ed for 
androstaned io ls, testosterone, DHT, and androstened ione, respectively . AU 
zones visualized were circled and each lane was cu t into 10 sections for 
radioassay using a Beckman liquid sc inti ll ation counter to determine the 
percentage of each steroid synthesized. 
For determination of Sa-L)... activity, counts from the DHT and andro-
stanedio l areas were summed and background was subtracted. Counts 
above background were noted only for DHT, testosterone, and andro-
stenedione . Enzyme activity was calculated using the net percen t conversion 
of 11 ,2-3 1-1] testosterone to DHT and androstanedio ls. . 
Preliminary Characterization of Sa-Reductase in Isolated Seba-
ceous Glands Pre liminary studies to val.idatc our methodology and to 
characteri ze the Scr-R enzyme were performed in isola ted sebaceous glands 
from the sca lp as large r quantities of th.i s tissue were available . T hese studies 
included demonstration of the pl-1 and co-factor dependence of the enzyme, 
and determination of the optimal incubation time and minimal quantity of 
sebaceous gland enzym e protein required to ca rry o ut the reaction. 
Incubation studies of homogenized glands were performed at pH 4, 5, 6, 
7 . and 8 to demonstrate the pH profi le o f 5cr-R activity. T he dependence of 
Scr-K activity on the presence of co-factor was demonstrated in incubation 
studies using homogenized sebaceous glands from the sca lp in the presence 
of500 j.LM ofNADP, NADPI-I , NAD, and NADJ-1 atpl-1 7. To determine 
the o pti.1nal in cubation tin1c for th is assay~ in cubatio n studies were per-
formed at pl-1 7 us i11 g sebaceous gland homogenates from the sca lp w ith 
incubation times of 10, 60, and 120 min. Incubation studies with varying 
quantities of sebaceous gland homogenate prote in (42.5, 85, 170, and 340 
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{.Lg) were performed at pH 7, to demonstrate that the for mation of product 
(DHT) was linear with the amount of enzyme used . 
Kinetics of Scr-R were determined using a sebaceous g land homogenate 
obtained from the temple and the scalp. T hese homogcna tes were incubated 
with varying concentrations of substrate (testosterone) at pH 7 to generate 
substrate curves. Values for apparent K,, and V""'" of Scr-R for testostero ne 
were estimated by Linewcavcr-Burk plot using this data. 
Determination of pH Dependence of Sa-Reductase in Isolated 
Sebaceous Glands and Whole Skin from Face, Scalp, and Non-
Acne-Prone Regions To determine whether the type 1 or type 2 
isoenzyme of 5a-R is operative in isolated sebaceous glands and whole skin 
fro m face, sca lp , and non-acne-prone areas, incubation studies were 
performed in duphcate as described above with 500 p.M N ADPI-1, at pH 5 
(optimum for type 2) and pl-1 7 (optimum for type 1). As a con trol, studies 
were also run using a purified recombinant type 1 and recombinant type 2 
reductase. T he ratios of activ ity at pH 5 and pH 7 were calculated for all 
samples and controls to assist iJJ isozyme identification . Comparisons using 
a pai red t test were made between Scr-R activities at pH 5 and pH 7 in both 
sebaceous g lands and w hole skin each obt<tined from each area . 
Inhibition Studies L-652, 918 (N-[1 , 1-dimeth ylethyl]-3-oxo-4-aza-Sa-
androstan-17 {3-carboxamide) and L-733 ,692 ( 4-aza- 4, 7 {3-dimethyi-Scr-
cho lestan-3-one) were provided by D rs. G. Rasm usson and R . Bakshi , 
Department of Synthetic C hemical Research , Merck & Co, respectively. 
T hese compounds and 13-cis retinoic acid were di ssolved in ethanol and 
seria lly diluted to the appropriate concentration. Experiments to determine 
the potency of these inhibitors were conducted at 500 p.M N ADPH and K,, 
concentrations ofT tha t were previously determined to be 7 p.M and 0.3 
p.M fo r the type 1 and 2 reductascs, respectively. T he 50'!!,, inhibi tory 
concentration represents th e concentration of inhibitor required to decrease 
enzyme activity to 50% of the control. 
RESULTS 
Effects of pH, Co-Factor, Incubation Time, and Protein 
Concentration on Sa-Reductase Activity in Isolated Seba-
ceous Glands T h e activity of the type 1 and 2 isozym es exhibit 
very distinctive pH profiles that can serve as a n indication of the 
isozyme conten t of a sample [1 S,l8] . T h e pH dependence of th e 
Sa-R in a sebaceou s g land h o m ogenate from scalp is sh own in Fig 
1. Optimal activ ity i s o b served at pH 6 .0 - 8.0. At pH 8, inc reased 
con version of testosterone to androstenedione b y 17,13-hydroxy-
steroid d ehydrogen ase (17 ,13-HSD) was noted. DHT production was 
linear w ith time between 10 min and 1 h . With lo n ger incubation 
times, more of the substrate, testos te ro n e, was converted to 
androstenedio n e 11in the 17,13-hyd roxysteroid d eh ydrogen ase (17,13-
HSD) enzym e. (Data n ot shown.) In subsequ e nt experim e nts (data 
n ot shown) Sa-a.ndrostanedione was added as a carrier stero id and 
the Rr was fo und to be 0.8. Retrospective review of all TLC plates 
fai led to reveal radioactive counts in tlus region, indicatin g that 
Sa-androstanedione was n ot produced. Dihydrotestosterone was . 
th e only Sa-redu ced produ ct note d in o ur experim ents . 
In isolated sebaceou s g lands from the scalp, th e amount of 
product (DHT) formed was linear with the amount of enzyme 
protein (above 80 /-Lg). In seb aceou s g lands fro m fac ial areas su ch as 
the nose, temple, cheek, eyelid, and foreh ead , o nly 40 /-Lg of protein 
were required to d e m onstrate en zym e activity. 
T h e co- factor re quirement of Sa-R in iso lated seb aceous g lands 
from the scalp was determined in the p resen ce ofNADPH, NADH, 
NADP+ , a nd NAD + . T h e enzym e activity in the sebaceou s g land 
h omogenate was dependent o n th e presence of NADPH; less than 
10%, of the activity was o b served when NADH re placed NADPH. 
As expected , there were n o d etectable Sa-reduced produ cts ob-
served w h en e n zyme was incubated with NADP+ or N AD + . 
However, in mixtures containing NAD + , con side rable con version 
of testosteron e to androstenedione by 17 {3-hydroxysteroid d e h y-
drogenase was observed. 
U sing a L in ewcaver-Burk plot, th e K, of th e type 1 Sa-re ductase 
at pH 7 in seb aceou s g land s obtained from the temple (Fig 2) and 
sca lp are esti mated a t 1S.6 ::±:: 1 .2 1-LM (mean ::±:: SD) and S.O ::±:: 0 . 7 
!-LM (mean ::±:: SO), respective ly . T h ese values compare favorab ly 
with those previously reported for th e recombin ant type 1 e n zym e 
[1 4,1 8] . 
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Figure 1. pH dependence of Sa-reductase activity. In these experi-
ments, Sa-reductase activ ity was assayed by incubating homogenized tissue 
with lOr' dpm [1,2-' H] testosterone, 1 fLM testosterone, SOU fLM NADPH , 
and 1 mM DTT at pH 7 at 37°C, S'X• C02 for 30 min. n) In isolated 
sebaceous glands from the sca lp. peak Sa-reductase activity is observed at 
pH 7 indicating the presence of the type 1 isozyme. At higher pH, increased 
activity of 17/3-hydroxysteroid dehydrogenase was noted. b) In whole scalp 
tissue, Sa-reductase exhibits peak activity at pl-1 6 through 8, also indicating 
presence of the type 1 isozyme . Each data point represents the mean of two 
determinations, with SEM less than 0.03 in each case. 
Type 1 Sa-Reductase Predominates in Sebaceous Glands 
and Whole Skin from Face, Scalp, and Non-Acne-Prone 
A.reas A total of 49 samples from 23 male and 21 female subjec ts 
without acne (age range, 16 to 81 years, 56 :!: 20 years [mean :!: 
SD]) was analyzed. The ratio of enzyme activity at pH 5 to pH 7 
was 0.1 with recombinant type 1 reductase and 5.2 with the 
recombinant type 2 isozyme. In incubation studies performed at pH 
5 and pH 7, the ratio of activity at pH 5 to activity at pH 7 was 0.08 
± 0.01 (mean :!: SEM) for sebaceous g lands from facial skin, 0.2 :!: 
0.03 (mean :!: SEM.) for whole skin from facial areas, 0.10 for both 
sebaceous g lands and whole skin from scalp, and 0.1. :!: 0.05 (mean 
± SEM) for sebaceous glands from non-acne-prone areas (Table 
I). These data are in concordance with the ratio obtained with the 
recombinant type 1 isozyme and thus demonstrate, in addition to 
the kinetic data, the predominance of tlus isozym e in sebaceous 
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Figure 2. Lineweaver-Burk plot of Sa-reductase activity in iso-
lated sebaceous glands from the tentple. Forty micrograms of seba-
ceous gland protei.n were incubated at pH 7 in the presence of 1, 2.S, 5, 7, 
·r 0, 20. 30, or 60 fLM cold testosterone, 1 O'' dpm [1.2-'HJ testosterone, 500 
fLM NADPI-1 , and 1 mM DTT at 3rC, S% CO, for 30 min. The K of 
the type 1 Sa-reductase is estimated at "15.6 :t t .2 "M and the V "' is r- 111".:\. 
approximately 3S pmol / min / mg . 
glands and whole skin obtained from face, scalp, and non-acne-
prone region s. 
Sa-Reductase Activity Is Concentrated in Sebaceous 
Glands Comparison of enzym e activity in iso lated sebaceous 
glands and whole skin reveals that 5a-R activity is concentrated in 
the sebaceous g lands (Fig 3). T his observation perta.i11s to samples 
from the face, scalp, and non-acne-prone regions . T h e ratio of 
activity at pH 5 to activity at pH 7 in whole skin fl-om fitcial areas 
was signifi cantly higher than that found i.J1 sebaceous g lands isolated 
from these areas (p = 0.004). This may reflect a possible contribu-
tion of type 2 activity fi·om other cell types present in whole skin . 
Sa-Reductase Exhibits Regional Differences in Activity 
Overall, the activity of Sa-R (mean :!: SEM) was sigJuficantly 
h.ighe r in fucial and sca.lp skin (acne-prone areas) compared to 
non-a cn e-prone areas for both sebaceous g lands and whole skin (32 
:!: 6 versus 6 :!: 3 pmol/min/mg protein , p = 0.03, paired t test for 
sebaceous g lands and 22 :::!:: 8 versus 0. 7 :!: 0.2 pmollmin/mg 
protein, p = 0.04, paired t test for whole skin) (Fig 3). 
Sa-Reductase Is Inhibited by an Azasteroid, But Not 13-cis 
Retinoic Acid The 4-azasteroids, L-733,692 and L-652,918, 
and 13-cis retinoic acid were tested for their ability to inhibit the 
5a-R activity in sebaceous g land. L-733,692 is a potent inhibito•· of 
the type 1 Sa-R. [25] as well as the enzyme activity in the sebaceo us 
gland (50% inhibitory concentration, = 15 nM; Table II). 
L-652,91 8, the selective inhibitor of tl1e type 2 5a-R, is a poor 
inlubitor of the activity in the sebaceous gla~~d (50% inhibitory 
concentration, 700 nM.) . There was poor inhibition of both 
isozym es of 5a-R by 13-cis rctinoic acid (Table II, 50% inhibitory 
concentration greater than 10,000 nM). 
DISCUSSION 
Although acne is influ en ced by androgens, its presence 111 many 
cases does not con·clate with e levated serum androgen levels [5]. 
Tlus raises the question whether there is increased local production 
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Table I. Sa-Reductase Activity in Isolated Sebaceous Glands and Whole Skin" 
Sebaceous Gland Activity 
(pmol/n~n/mg protein) 
Sitc1' n' pH s" pH 7'' 
Facial 
Temple 4 2.9 ::':: 1 .4 36 :±: 18 
Forehead 4 3.6 ::':: 3 34 ± 30 
Eycl.id 2 2.4 (2 .3,2 .5) 42.0 (41 ,43) 
Ear 2 2.5 (2.4,2.6) 24.0 (21,29) 
Nose 6 0.5 (0 .5,0 .5) 38 ± 7 
Cheek 2 ND~ 6.0 
Ratio 
pH 517r n 
0.08 8 
0.1 J 2 
0.06 2 
0.1 2 
o.o·t 8 
< 0.1 8 
Whole skin Activ ity 
(pmol / min / mg protein) 
pH 5 
2.7 :±: 1.3 
2.2 (1.9,2.4) 
0.2 (0. 2,0.2) 
pH 7 R;ltio pH 5/7 
0.19 
0.24 
0.14 
Mean ± SEM 3 ::':: 0.8 32 :±: 6 0.08 ± 0.01 
NO 
2 .7 ± 1.7 
3.2 ± 1.6 
2.8 ± 0.7 
14 :±: 7 
9.2 (8.9,9.4) 
1.4 (1.46.1.39) 
4.5 (4.0,4.7) 
12. 1 ± 6.7 
47 :±: 24 
22 ::':: B 
< 0. 1 
0.22 
0.07 
0.2 ::':: 0.03 
Non-acne-prone 
Bt·east 2 1.6 (1 .3,1 .9) 
Leg 2 ND 
Lower back 2 0.2 (0.2 ,0 .2) 
Arm 4 0.8 ::':: 0.3 
Abdomen 8 0.7 ::':: 0.4 
Mean ± SEM 0.6 ::':: 0.2 
Scalp 10 
16.2 (15 .6,16.6) 0.1 
NO 
2.7 (2.4,3.1) 0.08 
4.9 ± 0.7 0.16 
9.2 ± 4.9 0.08 
6 ± 3 0.1 ± 0.05 
35 ± 7 0.1" 
10 
2 
2 
2 
4 
10 
0.4 ::':: 0.15 
NO 
NO 
NO 
NO 
0.8 ± 0.3 
NO 
1.3 (1.4,1.2) 
1.0 (0.9 ,1.1) 
0.2 :±: 0. 1 
0.7 ± 0.2 
5.5 :±: 0.9 
0.5 
,. Incubatio n of sebaceous g land and w ho le skin homogcnatcs fro m various :111:1tomic are as were performed :1t pH 5 and pH 7 in the presence of 1 tniUion dpm tritiated 
testosterone, 10 IJ.M cold testoste rone , 500 1J.M NADPH, I mM o ·n · at 37"C, S'X• C02 for 30 min . 1
' Anatomic site from w hi ch samples we re obta ined. 
' n = number of samples: d upli catc samples were run fo r each subject. r.:or samples where n = 2, d:ua is expressed as m e:111 (r<mgc); for other s;-,mples. data is expressed as m ean 
:!: SEM . 
'
1 Sa-reductase :1ctivity at p1-f 5. 
~ Sa-redu ctase activity at pl-1 7. 
f T he ratio of So-reductase activity at pH 5 to t hat at pH 7. 
x ND, n o n e dctcctahlc . 
h Ratio of Sa-reductase at pH 5 to tlwt nt p H 7 calcul ated for four o f 10 sc:llp s;~mpl cs \vhc rc da[a at pH 5 was ava il ab le. 
of androgens within t he sebaceou s g land leading to increased 
sebum secretion in those affected with acne. Studies have shown 
that sebum productim1 is dependent upon tissue androgen action in 
that androgen-in sensitive subjects who lack functional androgen 
recepto rs do not produce sebum [26]. Testosterone and DHT can 
both bind to the androgen receptor, so either or both of these 
ho rmo nes migh t serve as th e effector a ndrogen in sebum produc-
tion. R ecent clinical studies have found that both sebum produc-
tion and the developme nt of acne in prepubertal children corre late 
w ith senm1 levels ofDREAS, an adrenalJ.y-derived androgen [7,8] . 
T issue response to DH£AS, however, probably requires conversion 
of serum DHEAS to more potent a ndrogens such as testostero ne 
and DHT throu gh th e action of steroidogenic en zym es such as 
Sa-reductase and othe rs. Previously, in vestigators have demon-
strated that isolated sebaceous glands, whol e skin , skin sli ces, and 
skin ho m ogenates are ;a ble to syn thesize androgens from precursor 
steroids such as DHEAS [13,23,27-3 1]. 
Two isozymes of Sa-Il... have bee t1 identified in skin and there 
appear to be regional differences in their distribution. T he type 1 
Sa-R has been identified in culture d derma l papilla ceUs from the 
occipital scalp, whole occipital scalp skin, . chest skin , and by 
immuno histoche mistry in the sebaceous glands fi·om pubic skin 
[17-20] . Activity of th e type 2 isozyme of Sa-R has been i_d entifi ed 
in cultured dermal papilla cells from the bea rd region [l7] and in 
scrotal skin (G. Harr is, K. Ellsworth, personal communication). 
Based on our pH and kinetic studies , we bave now demonstrated 
that sebaceous glands from the face, scalp, and non-acne-prone 
areas of skin convert testosteron e to DHT 11ia the type 1 Sa-l'l 
enzym e. T he lo w leve l of activi ty o bse rved at pH 5 might suggest 
the presence of the type 2 isozy m e in some o f these sa mples. The 
significan ce of this o bservation is n ot known . 
Previous studies using isolate d glands suggest that sebaceous 
glands m ay represent concen trated sources of steroidogeni c en-
zymes such as 17 {3-J1ydroxysteroid deh ydrogenase (17 {3-HSD) 
[9,10] . U sing immunohistoche mical 111e thods, 3a- and 3{3-hydroxy-
steroid d ehydrogenase (3a- and 3(3-HSD) have also been localized 
within sebaceous g lands [11]. Much of what we know rega rding the 
activity of Sa-Rin th e skin, however , is based o n studi es of who le 
skin that contain s a variety of cell types. M any of these cell types, 
particularly fibroblasts and keratin ocytes, demonstrate Sa-R activ-
ity [3 2]. B y iso lating sebaceous glands through microdissection , we 
were able to eliminate other cell types fi·om the sample to assess 
more accurately the activity of Sa-R in the sebaceous gland . Our 
data demonst rate that the activi ty of Sa-R, in general, is two- to 
fiftyfold highe r in iso lated sebaceous glands compared to whol e 
skin from the f.1ce, scalp , and non-acne-prone areas. 
Investiga tors have h ypothesi zed that diffe ren ces in androgen 
m etabolism at th e targe t tissue level m ay account for the presence 
of such conditio ns as male-pattern baldness, hirsutism, and acne. 
For example, studies involving sebaceous glands isolated from the 
scalp have d emonstrate d increased 3{3-HSD enzyme activity in bald 
scalp [23 ). W e and others have hypothesized that an analogous 
situation may exist in the expression of Sa-R within the sebaceous 
gland in skin from acne-prone area s such as the face and scalp 
compared to skin from regions not affected by acne [30]. Early 
expe riments demonstrated that acne-bea rin g skin produced more 
DHT than nonnal ski n and that norma l facia l skin prod uced mo re 
DHT than normal back skin, suggesting tha t indiv iduals with acne 
may have increased end-organ sensitivity to androgens that ma y be 
a function of the rate of conversion of tes tosterone to DHT [29,30] . 
Because sebaceous glands are larger in regions of skin prone to 
acne, such as the face [33 ,34], the question remained whether the 
increased conversion of testosterone to DHT observed in that study 
was a res ult o f increased sebaceous gland volum e rather th an actual 
increased activity of the Sa-R enzym e. By studying isolated 
sebaceous glands we were able to standardize the amount of protein 
assayed from each anatomic area to correct for differences in 
sebaceous g land volume. T he activity of Sc:x-R per milligram of 
protein is grea ter in fa cial and sca lp skin compared to skin fi·om 
regions not prone to acne. These data de monstrate that there are 
regio nal diffe re nces in Sc~-R activity, suggesting that acne-prone 
skin has an in creased capacity for local production of DHT. Of 
note, however, is that the samples in our study were obtained from 
subjects without acne and who for the most part are o lder than the 
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Figure 3. Sa-reductase activity in whole skin and sebaceous 
glands. Samples from fitce, scalp. and non-acne-prone skin were incubated 
with 106 dpm [1,2-3 HJ testosterone, 10 !J.M testosterone, SOO !J.M NADPH . 
and 1 mM DTT at 37°C, S% C02 for 30 min at pH 5 (stippled bars) and pH 
7 (lwtc/J ed bars) to detem1ine Sa-reductase activity . A) Sa-reductase activity 
i11 homogena tes of isolated sebaceous gla.nds. ln these experiments , the type 
1 isozyme (pH 7) predominates and its activity (mean :!:: SEM) is signifi -
cantly higher in fac ial skin (32 :t 6, n = 1 0) and the scalp (35 :t 7, n = S) 
compared to non-acne-prone skin (6 :t 3, n = 9) . p = 0.014 and 0.007, 
respectively. B) Sa-reductase activity in homogenates of whole skin. The 
type 1 isozyme also predominates in whole skin and its activity (mean :!: 
SEM) is significantly ltighcr in facial skin (22 :t 8, n = 1S) and scalp. (5 .5 
:t 0.09, n = S) compared to non-acne-prone skin (0.7 :t 0.2, n = 10) . p = 
0.017 and 0.012, respectivdy. 
adolescent popu lation in which this disease is m ost prevalent. A lso , 
there are interindividual diKeren ces in the enzyme's activ ity within 
a natomical areas . Wheth e r sebaceous g lands from acn e patients 
possess increased 5a-R activi ty compared to norm al patients re-
mains to be determined. 
T his study demonstrates that no ne of the enzyme activity in the 
sebaceous g land was resistant to the type 1 se lective inhibitor 
(L-733,692), nor was any of the activity inhibited by a type 2 
selective inhibitor (L-65 2,918) . It is therefore not surprising th at 
finasteride, a type 2 Sa-R inhibitor, does not inhibit sebum 
prod uction clinica ll y [25). Several clin icaJ studies have suggested 
t h at 13-cis retinoic acid may inhibit Sa-R activ ity both in the liver 
and the skin [21,22] . Whether this effect is di rect or indirect has not 
previously been tested o n the isozym es of Sa-It in human seba-
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Table II. Inhibition of Sa-Reductase" 
50% Inhibi tory Concentration (nM)' 
13-cis 
Tissue'' L-733,692'. L-652,9181 R.etinoic Acid Type" 
Sebaceous gland 7 860 > 10,000 
Scalp 20 700 > 10,000 1 
Prostate > 1,000 8 > 10,000 2 
" Experiments to determin e the potency of these inhibi tors were conducted o n 
homogenized sebaceo us glands, ho mogenized w ho le scalp skin, and homogenized 
prostate at 500 JLM NADPH and K11 , concen trations of tcstosrcronc tlwt were 
previously determined to be 7 J.LM and 0.3 J.LM for the type 1 and 2 rcductases . 
respectively. 
" Source of sa mple tissue . 
(Co ncentration of inhibitor required to decrease C ll Z )'lllC activity to SOo/1) of the 
control . 
'
1 Isozym e of Sa-reductase prese nt in the sam ple. 
(> A selective inhibitor of the t)'PC I Scr-rcductasc. 
f A selective inhibitOr of the type 2 Sa-reductase. 
ceou s g lands. Ow· studies show that 13-cis retinoic acid is a poor 
inhibitor of both isozym es of Sa-R (SO% inhibitory concen trations 
grea ter than 10,000 nM) . A m ore likely explanation fo r the acti on 
of 13-cis retinoic acid on th e activity of Sa-R is by decreasing th e 
sebaceo us g land volum e by an as ye t undefin ed mechanism . 
T herefore, as previously suggested by Lookingbill ei nl [35], this 
drug m ost like ly exerts an indirect effec t on Sa-R by redu cing the 
volume of the e nzyme-producin g tissue and consequently reducing 
the am o unt of Sa-R. 
fn summ ary, the resul ts of this stud y indicate that hwnan 
sebaceous glands con vert testosterone to DHT via the type 1 
Sa- reductase, which is enriche d in the sebaceous g lands compared 
to whole skin. Furtherm ore, we have shown that in no rmal subj ects 
(ages 16 to 81 yea rs) the activity of the type 1 isozyme is greater in 
skin from acne-pro ne regions such as th e face and scalp compared 
to non-acne- pron e skin. A lth ough these find ings are suggestive, 
they do not prove th at sebum production is dependent upon DHT 
formation in sebaceous glands . Additional studies using se lective 
type 1 inhibitors such as L-733 ,692 m ay h elp to further elucida te 
the role of testosterone an d DHT in sebum produ ction and acn e. fn 
p articular, if these inhibitors decrease sebum production clini cally, 
they may prove to be of therapeutic benefit in acne. 
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